Judge Collyer Named to Intelligence Surveillance Court
Judge Rosemary M. Collyer of the D.C. District Court was appointed by the Chief Justice of the United States to a seven year term on the Foreign Intelligence Surveillance Court. The Court provides a measure of judicial oversight over surveillance activities under the Foreign Intelligence Surveillance Act, as amended.
Judge Collyer’s term on the FIS Court began on March 8, 2013 and will conclude on March 7, 2020. She replaces Judge John D. Bates, whose term ended on February 21. Her appointment was confirmed by Sheldon Snook, spokesman for the Court.
A roster of the current membership of the Foreign Intelligence Surveillance Court can be found here.
The Court has acknowledged receipt of a letter from several members of the Senate requesting that the Court prepare summaries of its legal interpretations of the Foreign Intelligence Surveillance Act in order to facilitate their declassification and public release. But no further action has yet been taken by the Court, as far as could be determined.
Judge Collyer was appointed to the bench by President George W. Bush. In September 2011, she authored an opinion accepting the CIA’s view that for the CIA merely to acknowledge the fact that it had an interest in the use of drones for targeted killing would pose unacceptable damage to national security.
Today, the DC District of Appeals unanimously reversed Judge Collyer’s decision. The appeals court said the CIA was adhering to “a fiction of deniability that no reasonable person would regard as plausible.” The case — American Civil Liberties Union v. Central Intelligence Agency — was remanded to Judge Collyer for further processing.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.
Inconsistent metrics and opaque reporting make future AI power‑demand estimates extremely uncertain, leaving grid planners in the dark and climate targets on the line